Kerry Nichols on a Nurse Navigator-Led Smoking Cessation Program

Video

Kerry Nichols, RN, BSN, OCN, explains their nurse navigator-led smoking cessation program.

Kerry Nichols, RN, BSN, OCN, from Billings Clinic Cancer Center, explains their nurse navigator-led smoking cessation program.

Recognizing that providers don't have enough time to fully addressing smoking cessation, nurse navigators at Billings took steps to fill the gap. They adopted a plan of non-judgemental listening and motivational interviews. With the help of a pharmacists, they also discusses medication possibilities such as varenicline (Chantix) and bupropion (Wellbutrin) as well as non-nicotine replacements.

Recent Videos
5 experts in this video
5 experts in this video
Image of Jessie Desir, PhD, RN, AMB-BC, OCN, in a video call with a blue and gold Oncology Nursing News border surrounding the frame.
5 experts in this video
5 experts in this video
Related Content
Line illustration of lungs on a cornflower blue background

Osimertinib Sustains OS Improvement in EGFR-Mutant NSCLC

Roman Fabbricatore
March 31st 2025
Article

Osimertinib monotherapy and combination treatment had safety profiles consistent with previous data on use of the drug in EGFR-mutated NSCLC.

The Vitals

Nicole Gay Shares How She Counsels Patients on Lung Cancer Screenings

Lindsay Fischer
November 15th 2023
Podcast

Nicole Gay, APRN-C, shares how nurse navigators can talk to their patients about lung cancer screening.

Image of a calendar with a thumb tack stuck on a day reading "20," and a stethoscope lying on the calendar, with an image of a clock overlaying

Opinion: Oncology Nurses Can Ease the Burden of Time Toxicity in Cancer Care

Amanda Brink, DNP, APRN, FNP-BC, AOCNP
February 26th 2025
Article

Similar to financial toxicity, time toxicity can have a profound impact on a patient’s quality of life.

Oncology Nursing News

A Look Back at 2022 FDA Approvals in Oncology

Oncology Nursing News
January 2nd 2023
Podcast

In this episode of The Vitals, we recount the oncology drugs that received FDA approvals in 2022.

Simple light blue line illustration of a lung with a tumor on a dark blue background

Zipalertinib Achieves ORR Primary Endpoint in NSCLC Study

Kyle Doherty
February 3rd 2025
Article

Zipalertinib demonstrated efficacy in pretreated NSCLC with EGFR exon 20 insertion mutations, meeting the primary endpoint of ORR in the REZILIENT1 study.

blue background with a yellow notepad that says side effects in red writing

Ponsegromab Eases Cancer Cachexia Symptoms, Targets GDF-15

Roman Fabbricatore
January 21st 2025
Article

Patients receiving ponsegromab experienced significantly greater weight gain and physical activity than those receiving placebo.